Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 9/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 7/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 7/20 | 0.34 |
| ▸ | DRD2 | P14416 | 5/20 | 0.34 |
| ▸ | DRD4 | P21917 | 5/20 | 0.34 |
| ▸ | DRD3 | P35462 | 5/20 | 0.34 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.34 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 3/20 | 0.31 |
| ▸ | NOS1 | P29475 | 3/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3342601 | 0.94 | ATAD2 (0.40) | ATAD2HDAC1HDAC8HDAC6CHRM1 | |
| SCHEMBL3344187 | 0.83 | ATAD2 (0.43) | ATAD2HDAC1HDAC8HDAC6CHRM1 | |
| SCHEMBL20594801 | 0.77 | LGMN (0.39) | ATAD2DRD2DRD4DRD3 | |
| SCHEMBL31714399 | 0.77 | ATAD2 (0.60) | ATAD2HDAC1HDAC8HDAC6CHRM1 | |
| SCHEMBL3605572 | 0.77 | ATAD2 (0.52) | ATAD2CHRM1CHRM2CHRM4CHRM5 | |
| SCHEMBL3599801 | 0.77 | ATAD2 (0.68) | ATAD2HDAC1HDAC8HDAC6CHRM1 | |
| SCHEMBL1744203 | 0.74 | HDAC1 (0.36) | ATAD2HDAC1HDAC8HDAC6CHRM1 | |
| SCHEMBL3345870 | 0.73 | KMO (0.42) | CHRM1 | |
| SCHEMBL30896361 | 0.71 | CYP11B2 (0.40) | ATAD2 | |
| SCHEMBL1744184 | 0.71 | CYP11B2 (0.40) | ATAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372865-B2 | Dihydropyridone amides as P2X7 modulators | ROCHE PALO ALTO LLC (US) | 2013-02-12 | — | — | US | claimed |
| US-8372865-B2 | Dihydropyridone amides as P2X7 modulators | ROCHE PALO ALTO LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-20100160373-A1 | DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS | ROCHE PALO ALTO LLC | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160373-A1 | DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS | P2RY1, P2RX3, P2RX1 | ATAD2 2666/4885HDAC1 1874/4885HDAC8 2538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.